Federated Hermes, Inc. Edwards Lifesciences Corp Transaction History

Federated Hermes, Inc.

$41.2 Billion
Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,624 shares of EW stock, worth $106,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,624

Previous 1,825 11.01%

Holding current value

$106,339

Previous $174,000 13.79%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$84.3 - $94.31 $16,944 - $18,956	-201 Reduced 11.01%	1,624 $150,000
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $12,912 - $17,009	-178 Reduced 8.89%	1,825 $174,000
Q4 2023 Jan 31, 2024	SELL	$61.71 - $77.76 $647,399 - $815,780	-10,491 Reduced 83.97%	2,003 $152,000
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $476,577 - $642,361	-6,879 Reduced 35.51%	12,494 $865,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $527,943 - $611,730	6,485 Added 50.32%	19,373 $1.83 Million
Q1 2023 May 08, 2023	BUY	$74.26 - $84.51 $669,528 - $761,942	9,016 Added 232.85%	12,888 $1.07 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $50.6 Million - $64.8 Million	-740,680 Reduced 99.48%	3,872 $288,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $85,747 - $111,688	1,041 Added 0.14%	744,552 $61.5 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $4.9 Million - $7.26 Million	-56,616 Reduced 7.08%	743,511 $70.7 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $2.53 Million - $3.18 Million	-24,807 Reduced 3.01%	800,127 $94.2 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $92,116 - $113,168	866 Added 0.11%	824,934 $107 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $167,022 - $199,223	1,623 Added 0.2%	824,068 $93.3 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $36,805 - $45,989	439 Added 0.05%	822,445 $85.2 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $19,591 - $22,576	-249 Reduced 0.03%	822,006 $68.8 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $28,891 - $36,765	-403 Reduced 0.05%	822,255 $75 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $807,086 - $1.05 Million	-12,012 Reduced 1.44%	822,658 $65.7 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $31.7 Million - $42.4 Million	550,969 Added 194.21%	834,670 $57.7 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $584,790 - $903,798	-11,158 Reduced 3.78%	283,701 $53.5 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $373,198 - $427,278	5,205 Added 1.8%	294,859 $68.8 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $1.61 Million - $1.97 Million	-26,092 Reduced 8.26%	289,654 $63.7 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $1.68 Million - $1.94 Million	-30,101 Reduced 8.7%	315,746 $58.3 Million
Q1 2019 May 10, 2019	SELL	$47.89 - $64.05 $488,717 - $653,630	-10,205 Reduced 2.87%	345,847 $66.2 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $14.5 Million - $17.8 Million	-312,639 Reduced 46.75%	356,052 $18.2 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $1.78 Million - $2.26 Million	-38,887 Reduced 5.5%	668,691 $116 Million
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $4.28 Million - $5.17 Million	-100,867 Reduced 12.48%	707,578 $103 Million
Q1 2018 May 09, 2018	SELL	$37.19 - $47.45 $1.19 Million - $1.52 Million	-31,992 Reduced 3.81%	808,445 $113 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $17,401 - $20,285	-515 Reduced 0.06%	840,437 $0
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $30.5 Million - $32.7 Million	840,952	840,952 $91.9 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Edwards Lifesciences Corp Transaction History